OncoPlex Diagnostics Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 25


  • Latest Deal Type
  • M&A

OncoPlex Diagnostics General Information


Provider of clinical proteomics and genetic mutation for the treatment of cancer patient. The company provides proprietary technology to solubilize tumor cell proteins from FFPE tissue for quantitation by mass spectrometry analysis.

Contact Information

Formerly Known As
Expression Pathology
Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Corporate Office
  • 9600 Medical Center Drive
  • Suite 300
  • Rockville, MD 20850
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoPlex Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 10-Sep-2015 Completed Generating Revenue
1. Later Stage VC 01-Jan-2008 0000 Completed Generating Revenue
To view OncoPlex Diagnostics’s complete valuation and funding history, request access »

OncoPlex Diagnostics Executive Team (5)

Name Title Board Seat Contact Info
Todd Hembrough Ph.D President, Proteomics, Chief Scientific Officer, Vice President & Head of Research and Development
You’re viewing 1 of 5 executive team members. Get the full list »

OncoPlex Diagnostics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoPlex Diagnostics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
TEDCO Venture Capital Minority 000 0000 000000 0
VentureCross Partners Venture Capital Minority 000 0000 000000 0
To view OncoPlex Diagnostics’s complete investors history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »